# Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. – FDA Inspection, Mar 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/ea9811aa-4107-436d-8e97-c772f1bed4ec
Source feed: FDA_Inspections

> FDA inspection 1230640 of Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd., March 22, 2024. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 211. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230640
- Company Name: Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
- Inspection Date: 2024-03-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 1106423 - 2019-09-10](https://www.keypedia.com/records/fda_inspections/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/fffa5f62-5ff7-461b-9118-e485bdad04e8)
- [FDA Inspection 1049653 - 2018-03-23](https://www.keypedia.com/records/fda_inspections/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/1ea9dae0-e4fd-4cb3-a59d-f9b811fe8d21)
- FDA Inspection 958528 - 2016-02-12
- FDA Inspection 888415 - 2014-06-26
- FDA Inspection 801261 - 2012-07-09

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/patty-p-kaewussdangkul/1f0961fc-216e-4580-830a-56a76c0e7cea)

Company: https://www.keypedia.com/companies/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/d07820ec-a994-41cb-b667-509183a6cc4a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
